14P Flat-dose nivolumab (NIVO) as second-line (2L) treatment (tx) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC): CheckMate 870 long-term results
Titel:
14P Flat-dose nivolumab (NIVO) as second-line (2L) treatment (tx) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC): CheckMate 870 long-term results
Auteur:
Lu, S. Cheng, Y. Zhou, J. Wang, M. Zhao, J. Wang, B. Chen, G. Feng, J. Ma, Z. Wu, L. Wang, C. Ma, K. Zhang, S. Liang, J. Song, Y. Wang, J. Wu, Y-L. Li, A. Huang, Y. Chang, J.